Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities

Abstract Premature ovarian failure (POF) is one of the common disorders found in women leading to 1% female infertility.Clinical features of POF are hypoestrogenism or estrogen deficiency, increased gonadotropin level, and, most importantly, amenorrhea.With the development of regenerative medicine, human Cargo Shorts mesenchymal stem cell (hMSC) therapy brings new prospects for POF.This study aimed to describe the types of MSCs currently available for POF therapy, their biological characteristics, and their mechanism Wooden Car Visor Clip Couple Card of action.

It reviewed the latest findings on POF to provide the theoretical basis for further investigation and clinical therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *